Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Urology
|
March 15, 2015
Reply: To PMID 25769779
R Veeratterapillay, D Greene
Annals of the Royal College of Surgeons of England
|
September 24, 2020
SDH-deficient renal cell carcinoma: a clinicopathological analysis highlighting the role of genetic counselling
Y Wilczek, A Sachdeva, H Turner, et al.
Annals of the Royal College of Surgeons of England
|
May 23, 2012
Adenoid cystic carcinoma of the breast: case report and review of literature
R Veeratterapillay, S Veeratterapillay, E Ward, et al.
Annals of the Royal College of Surgeons of England
|
March 29, 2017
Radical prostatectomy for locally advanced and metastatic prostate cancer
R Veeratterapillay, S S Goonewardene, J Barclay, et al.
Clinical Radiology
|
September 5, 2015
Contrast-enhanced CT in 100 clear cell renal cell cancers - an analysis of enhancement, tumour size, and survival
R Veeratterapillay, R Ijabla, D Conaway, et al.
Journal of Clinical Pathology
|
January 31, 2012
Accuracy of the revised 2010 TNM classification in predicting the prognosis of patients treated for renal cell cancer in the north east of England
R Veeratterapillay, R Simren, A El-Sherif, et al.
International Urology and Nephrology
|
August 13, 2015
Intraoperative and surgical specimen (ex vivo) ultrasound in the assessment of margins at partial nephrectomy
R Veeratterapillay, A Bromby, A Patel, et al.
Annals of the Royal College of Surgeons of England
|
November 8, 2012
Safety and efficacy of percutaneous nephrolithotomy for the treatment of paediatric urolithiasis
R Veeratterapillay, M B K Shaw, R Williams, et al.
The Journal of Urology
|
August 25, 2020
Reply by Authors
A Pilatz, K Dimitropoulos, R Veeratterapillay, et al.
Oncogene
|
February 12, 2019
The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
A C Hepburn, R E Steele, R Veeratterapillay, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Urology
|
March 15, 2015
Reply: To PMID 25769779
R Veeratterapillay, D Greene
Annals of the Royal College of Surgeons of England
|
September 24, 2020
SDH-deficient renal cell carcinoma: a clinicopathological analysis highlighting the role of genetic counselling
Y Wilczek, A Sachdeva, H Turner, et al.
Annals of the Royal College of Surgeons of England
|
May 23, 2012
Adenoid cystic carcinoma of the breast: case report and review of literature
R Veeratterapillay, S Veeratterapillay, E Ward, et al.
Annals of the Royal College of Surgeons of England
|
March 29, 2017
Radical prostatectomy for locally advanced and metastatic prostate cancer
R Veeratterapillay, S S Goonewardene, J Barclay, et al.
Clinical Radiology
|
September 5, 2015
Contrast-enhanced CT in 100 clear cell renal cell cancers - an analysis of enhancement, tumour size, and survival
R Veeratterapillay, R Ijabla, D Conaway, et al.
Journal of Clinical Pathology
|
January 31, 2012
Accuracy of the revised 2010 TNM classification in predicting the prognosis of patients treated for renal cell cancer in the north east of England
R Veeratterapillay, R Simren, A El-Sherif, et al.
International Urology and Nephrology
|
August 13, 2015
Intraoperative and surgical specimen (ex vivo) ultrasound in the assessment of margins at partial nephrectomy
R Veeratterapillay, A Bromby, A Patel, et al.
Annals of the Royal College of Surgeons of England
|
November 8, 2012
Safety and efficacy of percutaneous nephrolithotomy for the treatment of paediatric urolithiasis
R Veeratterapillay, M B K Shaw, R Williams, et al.
The Journal of Urology
|
August 25, 2020
Reply by Authors
A Pilatz, K Dimitropoulos, R Veeratterapillay, et al.
Oncogene
|
February 12, 2019
The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
A C Hepburn, R E Steele, R Veeratterapillay, et al.
Page
of 2